Mohamed Abdallah is a pharmaceutical industry leader with over 17 years of experience across the UAE, KSA, and Egypt. He has held senior roles within leading organizations including Julphar, Tabuk Pharmaceuticals, GlaxoSmithKline, and Sigma-Tec.

Currently he is Quality Director at Julphar, Mohamed leads end-to-end quality operations across a diversified pharmaceutical network supplying more than 40 countries in different continents. His scope spans sterile and non-sterile dosage forms as well as advanced drug substance manufacturing, ensuring compliance with global regulatory standards while supporting sustainable business growth.

Previously, as Site Head at Tabuk Pharmaceuticals in KSA, he led a specialty manufacturing site serving KSA, GCC, Jordan, and Africa where he successfully drove a tangible cost optimisation along with strengthened inspection readiness frameworks and supported new product launches and facility expansions.

During his tenure at GlaxoSmithKline (GSK) in Egypt, Mohamed served as Site Quality Head and member of the Site Leadership Team, successfully leading the site through multiple regulatory, corporate, and third-party audits, including pre-approval inspections. He played a pivotal leadership role during the COVID-19 crisis and complex corporate transition periods, maintaining regulatory trust while ensuring uninterrupted patient supply. Prior to this he led Analytical Lab and held different positions in the Production areas.